Swedish Orphan Biovitrum AB (publ) 13D and 13G filings for Cartesian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-08-10 08:40 am Purchase |
2020-07-31 | 13G | Cartesian Therapeutics, Inc. RNAC |
Swedish Orphan Biovitrum AB (publ) | 180,546 6.200% |
180,546 (New Position) |
Filing |